Nabiximols oromucosal spray continues to be evaluated in ongoing clinical trials in multiple sclerosis spasticity DUBLIN, June 28, 2022 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq:
/PRNewswire/ As the COVID-19 death toll exceeds 1,000,000 American lives, the virus continues to disproportionately impact kidney patients, especially.